Concepedia

David G. Breckenridge

DG

Statistics

Publications

29

Citations

2.7K

H-Index

22

Active since

1999

Affiliations

Gilead Sciences (United States)(Current)

McGill University

Monash Medical Centre

Harvard University

Massachusetts General Hospital

David G. Breckenridge is an author at Gilead Sciences (United States) specializing in life sciences, pharmacology, and apoptosis.

ORCID

Publications per year

1999–2024

29

Publications

29

Caspase cleavage product of BAP31 induces mitochondrial fission through endoplasmic reticulum calcium signals, enhancing cytochrome <i>c</i> release to the cytosol

David G. Breckenridge, Marina Stojanovic, Richard Marcellus et al. · The Journal of Cell Biology · 2003 · 528 citations · Full text

, , +17

Single-Cell Transcriptomics Uncovers Zonation of Function in the Mesenchyme during Liver Fibrosis

Ross Dobie, John R. Wilson‐Kanamori, Beth E. P. Henderson et al. · Cell Reports · 2019 · 426 citations · Full text

, , +17

Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation

Jamie Bates, Archana Vijayakumar, Sarani Ghoshal et al. · Journal of Hepatology · 2020 · 225 citations · Full text

, , +17

Caenorhabditis elegans drp-1 and fis-2 Regulate Distinct Cell-Death Execution Pathways Downstream of ced-3 and Independent of ced-9

David G. Breckenridge, Byung‐Ho Kang, David Kokel et al. · Molecular Cell · 2008 · 144 citations · Full text

, , +10

ASK1 contributes to fibrosis and dysfunction in models of kidney disease

John T. Liles, Britton K. Corkey, Gregory T. Notte et al. · Journal of Clinical Investigation · 2018 · 140 citations · Full text

, , +17

1–5 of 29